These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 26782435)
21. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level. Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
23. Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers. He Y; Chen X; Liu H; Xiao H; Kwapong WR; Mei J Cancer Biomark; 2015; 15(5):645-51. PubMed ID: 26406953 [TBL] [Abstract][Full Text] [Related]
24. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784 [TBL] [Abstract][Full Text] [Related]
25. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis. Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237 [TBL] [Abstract][Full Text] [Related]
26. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]. Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression. Jiang W; Fan H; Qian C; Ding J; Wang Q; Pang X BMC Cancer; 2016 Jan; 16():16. PubMed ID: 26758745 [TBL] [Abstract][Full Text] [Related]
28. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)]. Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482 [TBL] [Abstract][Full Text] [Related]
29. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy. Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414 [TBL] [Abstract][Full Text] [Related]
30. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis. Xu TP; Shen H; Liu LX; Shu YQ Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828 [TBL] [Abstract][Full Text] [Related]
31. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer. Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis. Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522 [TBL] [Abstract][Full Text] [Related]
33. The expression profile and clinic significance of the SIX family in non-small cell lung cancer. Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176 [TBL] [Abstract][Full Text] [Related]
34. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202 [TBL] [Abstract][Full Text] [Related]
35. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer. Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672 [TBL] [Abstract][Full Text] [Related]
36. CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients. Fung AS; Kopciuk K; Dean ML; D'Silva A; Otsuka S; Klimowicz A; Hao D; Morris D; Bebb DG PLoS One; 2021; 16(1):e0241240. PubMed ID: 33507926 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-153 expression and prognosis in non-small cell lung cancer. Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455 [TBL] [Abstract][Full Text] [Related]
38. Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor survival in non-small cell lung cancer. Zhao S; Qiu ZX; Zhang L; Li WM Tumour Biol; 2015 Jun; 36(6):4143-50. PubMed ID: 25596700 [TBL] [Abstract][Full Text] [Related]
39. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis. Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099 [TBL] [Abstract][Full Text] [Related]
40. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer. Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]